Table 2.
Clinical features of LGG patients from CGGA
| Clinical features | Total (170) | % | |
|---|---|---|---|
| Age | Age ≤ 45 | 129 | 75.88% |
| Age > 45 | 41 | 24.12% | |
| Gender | Female | 65 | 38.24% |
| Male | 105 | 61.76% | |
| Grade | WHO II | 97 | 57.06% |
| WHO III | 73 | 42.94% | |
| 1p/19q | Non-codel | 113 | 66.47% |
| Codel | 55 | 32.35% | |
| Unknow | 2 | 1.18% | |
| IDH | Mutant | 125 | 73.53% |
| Wildtype | 44 | 25.88% | |
| Unknow | 1 | 0.59% | |
| MGMT | Unmethylated | 70 | 41.18% |
| Methylated | 84 | 49.41% | |
| Unknow | 16 | 9.41% |